CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy

Anna M. Lee, Christopher Jepson, Peter G. Shields, Neal Benowitz, Caryn Lerman, Rachel F. Tyndale

Research output: Contribution to journalArticle

35 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1312-1314
Number of pages3
JournalCancer Epidemiology Biomarkers and Prevention
Volume16
Issue number6
DOIs
StatePublished - Jun 1 2007

Fingerprint

N Demethylating Oxidoreductases
Inhalation Administration
Nicotinic Agonists
Cutaneous Administration
Aryl Hydrocarbon Hydroxylases
Cotinine
Linkage Disequilibrium
Smoking Cessation
Nicotine
Genotype
Therapeutics
Cytochrome P-450 CYP2B6

Cite this

CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy. / Lee, Anna M.; Jepson, Christopher; Shields, Peter G.; Benowitz, Neal; Lerman, Caryn; Tyndale, Rachel F.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 16, No. 6, 01.06.2007, p. 1312-1314.

Research output: Contribution to journalArticle

Lee, Anna M. ; Jepson, Christopher ; Shields, Peter G. ; Benowitz, Neal ; Lerman, Caryn ; Tyndale, Rachel F. / CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy. In: Cancer Epidemiology Biomarkers and Prevention. 2007 ; Vol. 16, No. 6. pp. 1312-1314.
@article{79ec086101de4c4ab0424c82f98b8ae4,
title = "CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy",
author = "Lee, {Anna M.} and Christopher Jepson and Shields, {Peter G.} and Neal Benowitz and Caryn Lerman and Tyndale, {Rachel F.}",
year = "2007",
month = "6",
day = "1",
doi = "10.1158/1055-9965.EPI-07-0188",
language = "English (US)",
volume = "16",
pages = "1312--1314",
journal = "Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy

AU - Lee, Anna M.

AU - Jepson, Christopher

AU - Shields, Peter G.

AU - Benowitz, Neal

AU - Lerman, Caryn

AU - Tyndale, Rachel F.

PY - 2007/6/1

Y1 - 2007/6/1

UR - http://www.scopus.com/inward/record.url?scp=34250841276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250841276&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-07-0188

DO - 10.1158/1055-9965.EPI-07-0188

M3 - Article

C2 - 17548706

AN - SCOPUS:34250841276

VL - 16

SP - 1312

EP - 1314

JO - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

JF - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

SN - 1055-9965

IS - 6

ER -